Skip to Content

Avax Technologies Inc - Stock Quote AVXT

Rating as of

Morningstar's Avax Technologies Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Avax Technologies Inc's Company Profile

Business Description

Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.

9200 Indian Creek Parkway, Suite 200
Overland Park, KS, 66210
T +1 913 693-8491
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2008
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 29